A
Adagio Medical Holdings, Inc. (ADGM)
NCM – Real Time Price. Currency in USD
0.92
-0.02 (-1.83%)
At close: May 12, 2026, 4:00 PM EDT
0.91
-0.02 (-1.82%)
After-hours: May 12, 2026, 5:02 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.92
-0.02 (-1.83%)
At close: May 12, 2026, 4:00 PM EDT
0.91
-0.02 (-1.82%)
After-hours: May 12, 2026, 5:02 PM EDT
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
| Name | Position |
|---|---|
| Dr. Alex Babkin Ph.D. | Chief Technical Officer |
| Mr. Antwan Gipson M.B.A. | Senior Vice President of Manufacturing & Operations |
| Mr. Ilya Grigorov | Vice President of Global Marketing & Product Management |
| Mr. Nabil Jubran | Chief Compliance Officer |
| Mr. Todd Usen | CEO & Director |
| Ms. Deborah Kaster | CFO & Chief Business Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 10-Q | adgm-20260331x10q.htm |
| 2026-04-30 | DEF 14A | ny20070401x1_def14a.htm |
| 2026-04-27 | 8-K | tm2612751d1_8k.htm |
| 2026-04-20 | 8-K | tm2612282d1_8k.htm |
| 2026-04-08 | 8-K | tm2611362d1_8k.htm |
| 2026-04-02 | POS AM | tm2610719d2_posam.htm |
| 2026-04-01 | POS AM | tm2610719d1_posam.htm |
| 2026-03-30 | S-8 | tm269982d1_s8.htm |
| 2025-12-11 | 8-K | tm2533309d1_8k.htm |
| 2025-11-24 | S-3 | adgm-20251121xs3.htm |
| Ms. Marie-Claude Jacques | Senior Vice President of Global Sales |
| Ms. Maryline Cullen | Corporate Controller |